When choosing dietary supplements, it is becoming increasingly clear that it is not only the active ingredient itself that plays a decisive role, but also its form and the method of delivery into the body. In recent years, liposomal supplements have come to the fore, representing a technologically distinct approach to supplementation. These are forms in which vitamins or other bioactive substances are enclosed in microscopic lipid vesicles – liposomes. These structures are particularly interesting because they are structurally similar to cell membranes, which creates the conditions for better interaction with the body. I believe that it is precisely this biological principle that lies behind the growing interest in this form of supplementation.
In this blog post, I will therefore take a closer look at how liposomal supplements work, how they differ from traditional forms, what the latest scientific findings suggest about their effectiveness, and what the future holds for them.
As mentioned in the introduction, a liposome is a microscopic particle formed by a phospholipid bilayer. The active ingredient, such as a vitamin or other bioactive compound, is enclosed within the liposome. This form protects the active ingredient from the harsh environment of the digestive tract, such as the acidic pH of the stomach or enzymatic degradation. At the same time, it facilitates easier penetration through biological membranes, as the liposome’s shell is similar to the cell membranes in the human body. Technologically, lecithin (sunflower or soya) is most commonly used; this is a natural source of phospholipids that enables the formation of this structure.
Conventional dietary supplements pass through the digestive tract, where the active ingredient may break down partially before it is absorbed. The liposomal form aims to circumvent this problem. Thanks to its protective coating, the active ingredient reaches the small intestine largely intact. It can then be absorbed more effectively, with the liposomes either fusing with cell membranes or being taken up by cells via endocytosis. Studies suggest that, for certain substances, this form may lead to higher bioavailability compared to conventional forms.¹
Recent studies suggest that liposomal forms may improve the bioavailability of certain nutrients, with vitamin C being the most extensively studied substance in recent years. According to research published in the journal Basic & Clinical Pharmacology & Toxicology (2025), liposomal vitamin C was found to have 1.2 to 5.4 times higher peak blood concentrations, as well as higher overall exposure to the body¹. This suggests that the body is able to process this form more effectively and keep it in circulation for longer.
Further studies suggest that liposomal vitamin C may offer advantages over conventional forms not only in terms of absorption, but also in terms of more efficient delivery to cells, including those of the immune system². At the same time, more stable vitamin C levels over time have been observed, indicating different pharmacokinetics compared to conventional forms³.
Research published in the *Journal of Liposome Research* (2025) takes the concept a step further and describes the shift from simple absorption to so-called targeted nutrient delivery⁴. This is an approach whereby active substances can be delivered precisely to the specific cells or tissues where they are intended to act. This is achieved by modifying the surface of the liposomes or by their reaction to the environment, such as pH or enzymes. I note that this field has so far been developed mainly in medicine, but its spillover into nutrition is becoming increasingly apparent. In the future, it may prove to be a significant tool for more precise nutritional intervention.
The growing importance of personalised nutrition, as highlighted in a systematic review published in the journal *Nutrients* (2025), takes into account genetics, metabolism and individual differences in nutrient absorption⁵. In this context, liposomal forms can serve as a flexible tool that allows supplementation to be tailored to an individual’s specific needs. I believe their importance will grow, particularly among people with reduced absorption or an increased need for antioxidants.
The liposomal forms of vitamin C, B vitamins, vitamin D, glutathione and curcumin are the most commonly found on the market today. These are substances for which bioavailability is of crucial importance to their effectiveness in the body.
In the context of modern liposomal formulations, combined products are also appearing on the market. One example is Sulforaphane EXTRA Liposomal Q10, which combines sulforaphane, coenzyme Q10 and liposomal technology. Coenzyme Q10 is important for energy metabolism in the mitochondria, and its levels naturally decline with age. The liposomal form ensures up to six times higher absorption of coenzyme Q10, leading to a faster onset of action and longer retention in the body. The combination of sulforaphane and liposomal Q10 provides antioxidant protection, detoxification and vitality support for the heart, brain and immune system. Standard sulforaphane has an absorption rate of approximately 70–80%; when combined with liposomal coenzyme Q10, bioavailability can reach as high as 95–97%.
I believe that the choice of these ingredients is no coincidence. Liposomal supplements may be suitable for a wide range of people, particularly those with increased nutritional requirements or specific needs.
In conclusion, I would note that liposomal dietary supplements represent a technologically advanced approach to supplementation. Their significance lies primarily in their ability to increase the bioavailability of active ingredients and improve their utilisation within the body.
Both modern research and practical experience suggest that the form of administration can play just as important a role as the supplement’s composition itself. I therefore believe that liposomal supplements are not merely a short-lived trend, but a natural development in nutrition and healthcare.
Mária Zajičková, PhD,
organic chemist and science communicator
1. Dos Santos, M., et al. (2025). Pharmacokinetics and bioavailability of liposomal vitamin C in humans. Basic & Clinical Pharmacology & Toxicology.
2. Pullar, J. M., Carr, A. C., & Vissers, M. C. M. (2024). The roles of vitamin C in skin health and immune function and its delivery via liposomal formulations. European Journal of Nutrition.
3. Kirby, D. F., & Leverett, B. D. (2024). Comparative absorption of liposomal and non-liposomal vitamin C in human subjects. Applied Sciences.
4. Zhang, H., et al. (2025). Advances in liposomal drug delivery and targeted nutrient transport systems. Journal of Liposome Research.
5. Fenech, M., et al. (2025). Personalised nutrition and variability in nutrient metabolism and absorption. Nutrients.
Glossary
Liposome – a cell-membrane-like lipid microparticle used to transport active substances.
Bioavailability – the proportion of a substance that is absorbed and utilised by the body.
Endocytosis – a cellular mechanism for taking up substances.
Phospholipids – the basic building blocks of cell membranes.
Pharmacokinetics – the behaviour of a substance in the body (absorption, distribution, metabolism, excretion).
Loyalty discount price 13% is 30,36 €
